Skip to main content
. Author manuscript; available in PMC: 2010 Aug 30.
Published in final edited form as: Cardiol Clin. 2009 May;27(2):291–Contents. doi: 10.1016/j.ccl.2008.12.004

Figure 2.

Figure 2

Summary of the various PET and SPECT radiopharmaceuticals to assess myocardial substrate metabolism. FTHA, F-18 fluoro-6-thia-heptadecanoic acid. FCPHA, trans-9(RS)-18F-fluoro-3,4(RS,RS) methyleneheptadecanoic acid, BMIPP. 123I-beta-methyl-P iodophenylpentadecanoic acid HK, Hexokinase; PFK, phosphorfructokinase; ADP, adenosine diphosphate; TCA; tricarboxcylic acid cycle; PDH, pyruvate dehydrogenase; TG, triglyceride; G3PDH, glyceraldehyde 3-phosphate dehydrogenase;αGP, alpha-glycerol phosphate. Reproduced with permission from Herrero P, Gropler RJ. Imaging of myocardial metabolism. J Nucl Cardiol 2005;12(3):345–358.